Company page

Calithera Biosciences, Inc.

Calithera Biosciences, Inc. (CALA) is a public company based in the United States, focused on developing innovative therapies for cancer and other serious diseases. With a market capitalization of approximately $2.4 billion, Calithera is actively engaged in advancing its drug candidates through clinical trials. The company aims to provide effective treatment options to improve patient outcomes in oncology.